nodes	percent_of_prediction	percent_of_DWPC	metapath
Lithium—GRIA3—Topiramate—obesity	0.589	1	CbGbCtD
Lithium—IMPA2—islet of Langerhans—obesity	0.00412	0.0541	CbGeAlD
Lithium—IMPA1—cardiovascular system—obesity	0.00397	0.0521	CbGeAlD
Lithium—IMPA2—respiratory system—obesity	0.00389	0.0511	CbGeAlD
Lithium—GSK3B—respiratory system—obesity	0.00381	0.0501	CbGeAlD
Lithium—GRIA3—adrenal cortex—obesity	0.0037	0.0486	CbGeAlD
Lithium—GSK3A—islet of Langerhans—obesity	0.00351	0.0461	CbGeAlD
Lithium—GSK3B—cardiovascular system—obesity	0.00292	0.0384	CbGeAlD
Lithium—GSK3A—adrenal cortex—obesity	0.00278	0.0366	CbGeAlD
Lithium—IMPA1—endocrine gland—obesity	0.00272	0.0357	CbGeAlD
Lithium—GRIA3—adrenal gland—obesity	0.00267	0.035	CbGeAlD
Lithium—IMPA2—pituitary gland—obesity	0.00264	0.0346	CbGeAlD
Lithium—IMPA2—adipose tissue—obesity	0.00263	0.0345	CbGeAlD
Lithium—GSK3B—adipose tissue—obesity	0.00258	0.0338	CbGeAlD
Lithium—GSK3A—cardiovascular system—obesity	0.00254	0.0334	CbGeAlD
Lithium—IMPA2—digestive system—obesity	0.00247	0.0325	CbGeAlD
Lithium—IMPA1—liver—obesity	0.00245	0.0322	CbGeAlD
Lithium—GSK3B—digestive system—obesity	0.00243	0.0319	CbGeAlD
Lithium—IMPA2—adrenal gland—obesity	0.00236	0.0309	CbGeAlD
Lithium—GSK3B—adrenal gland—obesity	0.00231	0.0303	CbGeAlD
Lithium—GSK3A—pituitary gland—obesity	0.00225	0.0295	CbGeAlD
Lithium—GSK3A—adipose tissue—obesity	0.00224	0.0294	CbGeAlD
Lithium—GSK3A—digestive system—obesity	0.00211	0.0277	CbGeAlD
Lithium—GRIA3—liver—obesity	0.00209	0.0274	CbGeAlD
Lithium—GSK3A—adrenal gland—obesity	0.00201	0.0264	CbGeAlD
Lithium—GSK3B—endocrine gland—obesity	0.002	0.0263	CbGeAlD
Lithium—IMPA2—liver—obesity	0.00184	0.0242	CbGeAlD
Lithium—GSK3B—liver—obesity	0.00181	0.0237	CbGeAlD
Lithium—GSK3A—endocrine gland—obesity	0.00174	0.0229	CbGeAlD
Lithium—GSK3A—liver—obesity	0.00157	0.0206	CbGeAlD
Lithium—Abdominal pain—Phendimetrazine—obesity	0.000433	0.00276	CcSEcCtD
Lithium—Nystagmus—Topiramate—obesity	0.000431	0.00275	CcSEcCtD
Lithium—Diarrhoea—Methamphetamine—obesity	0.000426	0.00272	CcSEcCtD
Lithium—Hypertonia—Bupropion—obesity	0.000424	0.0027	CcSEcCtD
Lithium—Thirst—Sibutramine—obesity	0.000423	0.0027	CcSEcCtD
Lithium—Agitation—Cimetidine—obesity	0.000417	0.00266	CcSEcCtD
Lithium—Somnolence—Phenylpropanolamine—obesity	0.000416	0.00265	CcSEcCtD
Lithium—Convulsion—Diethylpropion—obesity	0.000413	0.00263	CcSEcCtD
Lithium—Albuminuria—Topiramate—obesity	0.000413	0.00263	CcSEcCtD
Lithium—Stupor—Topiramate—obesity	0.000413	0.00263	CcSEcCtD
Lithium—Dizziness—Methamphetamine—obesity	0.000412	0.00263	CcSEcCtD
Lithium—Diarrhoea—Benzphetamine—obesity	0.000411	0.00262	CcSEcCtD
Lithium—Scotoma—Topiramate—obesity	0.000406	0.00259	CcSEcCtD
Lithium—Discomfort—Diethylpropion—obesity	0.000401	0.00256	CcSEcCtD
Lithium—Polyuria—Bupropion—obesity	0.0004	0.00255	CcSEcCtD
Lithium—Dizziness—Benzphetamine—obesity	0.000397	0.00253	CcSEcCtD
Lithium—Dry mouth—Diethylpropion—obesity	0.000397	0.00253	CcSEcCtD
Lithium—Dyspepsia—Phentermine—obesity	0.000394	0.00251	CcSEcCtD
Lithium—Memory impairment—Topiramate—obesity	0.000393	0.0025	CcSEcCtD
Lithium—Headache—Methamphetamine—obesity	0.00039	0.00249	CcSEcCtD
Lithium—Arthralgia—Cimetidine—obesity	0.000386	0.00246	CcSEcCtD
Lithium—Fatigue—Phentermine—obesity	0.000386	0.00246	CcSEcCtD
Lithium—Feeling abnormal—Phenylpropanolamine—obesity	0.000385	0.00246	CcSEcCtD
Lithium—Dry skin—Orlistat—obesity	0.000381	0.00243	CcSEcCtD
Lithium—Ataxia—Sibutramine—obesity	0.000379	0.00241	CcSEcCtD
Lithium—Headache—Benzphetamine—obesity	0.000376	0.0024	CcSEcCtD
Lithium—Diarrhoea—Phendimetrazine—obesity	0.000375	0.00239	CcSEcCtD
Lithium—Dehydration—Sibutramine—obesity	0.000375	0.00239	CcSEcCtD
Lithium—Confusional state—Cimetidine—obesity	0.000374	0.00238	CcSEcCtD
Lithium—Dry skin—Sibutramine—obesity	0.000369	0.00235	CcSEcCtD
Lithium—Thirst—Bupropion—obesity	0.000369	0.00235	CcSEcCtD
Lithium—Gastritis—Orlistat—obesity	0.000368	0.00235	CcSEcCtD
Lithium—Dizziness—Phendimetrazine—obesity	0.000362	0.00231	CcSEcCtD
Lithium—Lethargy—Bupropion—obesity	0.000358	0.00228	CcSEcCtD
Lithium—Nausea—Benzphetamine—obesity	0.000357	0.00227	CcSEcCtD
Lithium—Gastritis—Sibutramine—obesity	0.000356	0.00227	CcSEcCtD
Lithium—Muscular weakness—Sibutramine—obesity	0.000355	0.00226	CcSEcCtD
Lithium—Musculoskeletal discomfort—Diethylpropion—obesity	0.000355	0.00226	CcSEcCtD
Lithium—Abdominal pain—Phentermine—obesity	0.000354	0.00226	CcSEcCtD
Lithium—Somnolence—Diethylpropion—obesity	0.000346	0.00221	CcSEcCtD
Lithium—Headache—Phendimetrazine—obesity	0.000343	0.00219	CcSEcCtD
Lithium—Dyspepsia—Diethylpropion—obesity	0.000343	0.00218	CcSEcCtD
Lithium—Musculoskeletal discomfort—Cimetidine—obesity	0.000338	0.00215	CcSEcCtD
Lithium—Oliguria—Topiramate—obesity	0.000334	0.00213	CcSEcCtD
Lithium—Ataxia—Bupropion—obesity	0.00033	0.0021	CcSEcCtD
Lithium—Somnolence—Cimetidine—obesity	0.000329	0.0021	CcSEcCtD
Lithium—Dehydration—Bupropion—obesity	0.000327	0.00208	CcSEcCtD
Lithium—Dysarthria—Topiramate—obesity	0.000326	0.00208	CcSEcCtD
Lithium—Nausea—Phendimetrazine—obesity	0.000325	0.00207	CcSEcCtD
Lithium—Dry skin—Bupropion—obesity	0.000322	0.00205	CcSEcCtD
Lithium—Asthenia—Phentermine—obesity	0.000321	0.00205	CcSEcCtD
Lithium—Feeling abnormal—Diethylpropion—obesity	0.000321	0.00205	CcSEcCtD
Lithium—Erectile dysfunction—Sibutramine—obesity	0.000321	0.00204	CcSEcCtD
Lithium—Fatigue—Cimetidine—obesity	0.000319	0.00204	CcSEcCtD
Lithium—Weight increased—Sibutramine—obesity	0.000317	0.00202	CcSEcCtD
Lithium—Hyperglycaemia—Sibutramine—obesity	0.000314	0.002	CcSEcCtD
Lithium—Coordination abnormal—Topiramate—obesity	0.000314	0.002	CcSEcCtD
Lithium—Muscle twitching—Topiramate—obesity	0.000314	0.002	CcSEcCtD
Lithium—Gastritis—Bupropion—obesity	0.000311	0.00198	CcSEcCtD
Lithium—Muscular weakness—Bupropion—obesity	0.00031	0.00197	CcSEcCtD
Lithium—Dizziness—Phenylpropanolamine—obesity	0.000309	0.00197	CcSEcCtD
Lithium—Diarrhoea—Phentermine—obesity	0.000306	0.00195	CcSEcCtD
Lithium—Feeling abnormal—Cimetidine—obesity	0.000305	0.00195	CcSEcCtD
Lithium—Salivary hypersecretion—Topiramate—obesity	0.000299	0.00191	CcSEcCtD
Lithium—Depressed level of consciousness—Topiramate—obesity	0.000298	0.0019	CcSEcCtD
Lithium—Urinary incontinence—Topiramate—obesity	0.000298	0.0019	CcSEcCtD
Lithium—Vomiting—Phenylpropanolamine—obesity	0.000297	0.0019	CcSEcCtD
Lithium—Dizziness—Phentermine—obesity	0.000296	0.00189	CcSEcCtD
Lithium—Rash—Phenylpropanolamine—obesity	0.000295	0.00188	CcSEcCtD
Lithium—Dermatitis—Phenylpropanolamine—obesity	0.000295	0.00188	CcSEcCtD
Lithium—Body temperature increased—Cimetidine—obesity	0.000293	0.00187	CcSEcCtD
Lithium—Vomiting—Phentermine—obesity	0.000285	0.00181	CcSEcCtD
Lithium—Bradycardia—Sibutramine—obesity	0.000284	0.00181	CcSEcCtD
Lithium—Rash—Phentermine—obesity	0.000282	0.0018	CcSEcCtD
Lithium—Dermatitis—Phentermine—obesity	0.000282	0.0018	CcSEcCtD
Lithium—Headache—Phentermine—obesity	0.00028	0.00179	CcSEcCtD
Lithium—Erectile dysfunction—Bupropion—obesity	0.000279	0.00178	CcSEcCtD
Lithium—Urine output increased—Topiramate—obesity	0.000279	0.00178	CcSEcCtD
Lithium—Nausea—Phenylpropanolamine—obesity	0.000278	0.00177	CcSEcCtD
Lithium—Weight increased—Bupropion—obesity	0.000276	0.00176	CcSEcCtD
Lithium—Weight decreased—Bupropion—obesity	0.000275	0.00175	CcSEcCtD
Lithium—Hyperglycaemia—Bupropion—obesity	0.000274	0.00174	CcSEcCtD
Lithium—Hypertonia—Topiramate—obesity	0.00027	0.00172	CcSEcCtD
Lithium—Diarrhoea—Diethylpropion—obesity	0.000266	0.0017	CcSEcCtD
Lithium—Nausea—Phentermine—obesity	0.000266	0.00169	CcSEcCtD
Lithium—Asthenia—Cimetidine—obesity	0.000266	0.00169	CcSEcCtD
Lithium—Tinnitus—Sibutramine—obesity	0.00026	0.00166	CcSEcCtD
Lithium—Dizziness—Diethylpropion—obesity	0.000257	0.00164	CcSEcCtD
Lithium—Polyuria—Topiramate—obesity	0.000255	0.00162	CcSEcCtD
Lithium—Alopecia—Orlistat—obesity	0.000254	0.00162	CcSEcCtD
Lithium—Diarrhoea—Cimetidine—obesity	0.000253	0.00162	CcSEcCtD
Lithium—Arrhythmia—Sibutramine—obesity	0.000249	0.00159	CcSEcCtD
Lithium—Vomiting—Diethylpropion—obesity	0.000248	0.00158	CcSEcCtD
Lithium—Flatulence—Orlistat—obesity	0.000247	0.00157	CcSEcCtD
Lithium—Alopecia—Sibutramine—obesity	0.000246	0.00157	CcSEcCtD
Lithium—Rash—Diethylpropion—obesity	0.000245	0.00156	CcSEcCtD
Lithium—Dysgeusia—Orlistat—obesity	0.000245	0.00156	CcSEcCtD
Lithium—Dermatitis—Diethylpropion—obesity	0.000245	0.00156	CcSEcCtD
Lithium—Dizziness—Cimetidine—obesity	0.000245	0.00156	CcSEcCtD
Lithium—Headache—Diethylpropion—obesity	0.000244	0.00155	CcSEcCtD
Lithium—Hallucination—Bupropion—obesity	0.000242	0.00154	CcSEcCtD
Lithium—Flatulence—Sibutramine—obesity	0.000239	0.00152	CcSEcCtD
Lithium—Dysgeusia—Sibutramine—obesity	0.000238	0.00151	CcSEcCtD
Lithium—Vision blurred—Orlistat—obesity	0.000236	0.00151	CcSEcCtD
Lithium—Vomiting—Cimetidine—obesity	0.000236	0.0015	CcSEcCtD
Lithium—Thirst—Topiramate—obesity	0.000235	0.0015	CcSEcCtD
Lithium—Rash—Cimetidine—obesity	0.000234	0.00149	CcSEcCtD
Lithium—Dermatitis—Cimetidine—obesity	0.000233	0.00149	CcSEcCtD
Lithium—Headache—Cimetidine—obesity	0.000232	0.00148	CcSEcCtD
Lithium—Nausea—Diethylpropion—obesity	0.000231	0.00147	CcSEcCtD
Lithium—Angioedema—Orlistat—obesity	0.000229	0.00146	CcSEcCtD
Lithium—Vision blurred—Sibutramine—obesity	0.000229	0.00146	CcSEcCtD
Lithium—Lethargy—Topiramate—obesity	0.000228	0.00145	CcSEcCtD
Lithium—Tremor—Sibutramine—obesity	0.000227	0.00145	CcSEcCtD
Lithium—Tinnitus—Bupropion—obesity	0.000226	0.00144	CcSEcCtD
Lithium—Vertigo—Orlistat—obesity	0.000225	0.00144	CcSEcCtD
Lithium—Agitation—Sibutramine—obesity	0.000223	0.00142	CcSEcCtD
Lithium—Angioedema—Sibutramine—obesity	0.000222	0.00141	CcSEcCtD
Lithium—Nausea—Cimetidine—obesity	0.00022	0.0014	CcSEcCtD
Lithium—Vertigo—Sibutramine—obesity	0.000218	0.00139	CcSEcCtD
Lithium—Syncope—Sibutramine—obesity	0.000218	0.00139	CcSEcCtD
Lithium—Convulsion—Orlistat—obesity	0.000217	0.00138	CcSEcCtD
Lithium—Arrhythmia—Bupropion—obesity	0.000217	0.00138	CcSEcCtD
Lithium—Alopecia—Bupropion—obesity	0.000215	0.00137	CcSEcCtD
Lithium—Loss of consciousness—Sibutramine—obesity	0.000213	0.00136	CcSEcCtD
Lithium—Discomfort—Orlistat—obesity	0.000211	0.00134	CcSEcCtD
Lithium—Ataxia—Topiramate—obesity	0.00021	0.00134	CcSEcCtD
Lithium—Convulsion—Sibutramine—obesity	0.00021	0.00134	CcSEcCtD
Lithium—Dry mouth—Orlistat—obesity	0.000209	0.00133	CcSEcCtD
Lithium—Flatulence—Bupropion—obesity	0.000208	0.00133	CcSEcCtD
Lithium—Dehydration—Topiramate—obesity	0.000208	0.00133	CcSEcCtD
Lithium—Dysgeusia—Bupropion—obesity	0.000207	0.00132	CcSEcCtD
Lithium—Arthralgia—Sibutramine—obesity	0.000206	0.00132	CcSEcCtD
Lithium—Oedema—Orlistat—obesity	0.000205	0.0013	CcSEcCtD
Lithium—Discomfort—Sibutramine—obesity	0.000204	0.0013	CcSEcCtD
Lithium—Dry mouth—Sibutramine—obesity	0.000202	0.00129	CcSEcCtD
Lithium—Confusional state—Sibutramine—obesity	0.0002	0.00127	CcSEcCtD
Lithium—Vision blurred—Bupropion—obesity	0.000199	0.00127	CcSEcCtD
Lithium—Tremor—Bupropion—obesity	0.000198	0.00126	CcSEcCtD
Lithium—Gastritis—Topiramate—obesity	0.000198	0.00126	CcSEcCtD
Lithium—Oedema—Sibutramine—obesity	0.000198	0.00126	CcSEcCtD
Lithium—Muscular weakness—Topiramate—obesity	0.000197	0.00126	CcSEcCtD
Lithium—Shock—Sibutramine—obesity	0.000195	0.00124	CcSEcCtD
Lithium—Agitation—Bupropion—obesity	0.000194	0.00124	CcSEcCtD
Lithium—Angioedema—Bupropion—obesity	0.000193	0.00123	CcSEcCtD
Lithium—Vertigo—Bupropion—obesity	0.00019	0.00121	CcSEcCtD
Lithium—Syncope—Bupropion—obesity	0.00019	0.00121	CcSEcCtD
Lithium—Anorexia—Sibutramine—obesity	0.000189	0.0012	CcSEcCtD
Lithium—Musculoskeletal discomfort—Orlistat—obesity	0.000186	0.00119	CcSEcCtD
Lithium—Loss of consciousness—Bupropion—obesity	0.000186	0.00118	CcSEcCtD
Lithium—Hypotension—Sibutramine—obesity	0.000185	0.00118	CcSEcCtD
Lithium—Convulsion—Bupropion—obesity	0.000183	0.00117	CcSEcCtD
Lithium—Musculoskeletal discomfort—Sibutramine—obesity	0.00018	0.00115	CcSEcCtD
Lithium—Dyspepsia—Orlistat—obesity	0.00018	0.00115	CcSEcCtD
Lithium—Arthralgia—Bupropion—obesity	0.00018	0.00115	CcSEcCtD
Lithium—Erectile dysfunction—Topiramate—obesity	0.000178	0.00113	CcSEcCtD
Lithium—Discomfort—Bupropion—obesity	0.000178	0.00113	CcSEcCtD
Lithium—Decreased appetite—Orlistat—obesity	0.000178	0.00113	CcSEcCtD
Lithium—Fatigue—Orlistat—obesity	0.000176	0.00112	CcSEcCtD
Lithium—Dry mouth—Bupropion—obesity	0.000176	0.00112	CcSEcCtD
Lithium—Somnolence—Sibutramine—obesity	0.000176	0.00112	CcSEcCtD
Lithium—Weight increased—Topiramate—obesity	0.000176	0.00112	CcSEcCtD
Lithium—Weight decreased—Topiramate—obesity	0.000175	0.00111	CcSEcCtD
Lithium—Hyperglycaemia—Topiramate—obesity	0.000174	0.00111	CcSEcCtD
Lithium—Dyspepsia—Sibutramine—obesity	0.000174	0.00111	CcSEcCtD
Lithium—Confusional state—Bupropion—obesity	0.000174	0.00111	CcSEcCtD
Lithium—Oedema—Bupropion—obesity	0.000173	0.0011	CcSEcCtD
Lithium—Decreased appetite—Sibutramine—obesity	0.000172	0.0011	CcSEcCtD
Lithium—Shock—Bupropion—obesity	0.00017	0.00108	CcSEcCtD
Lithium—Feeling abnormal—Orlistat—obesity	0.000169	0.00107	CcSEcCtD
Lithium—Gastrointestinal pain—Orlistat—obesity	0.000167	0.00107	CcSEcCtD
Lithium—Anorexia—Bupropion—obesity	0.000164	0.00105	CcSEcCtD
Lithium—Feeling abnormal—Sibutramine—obesity	0.000163	0.00104	CcSEcCtD
Lithium—Gastrointestinal pain—Sibutramine—obesity	0.000162	0.00103	CcSEcCtD
Lithium—Abdominal pain—Orlistat—obesity	0.000162	0.00103	CcSEcCtD
Lithium—Body temperature increased—Orlistat—obesity	0.000162	0.00103	CcSEcCtD
Lithium—Hypotension—Bupropion—obesity	0.000161	0.00103	CcSEcCtD
Lithium—Bradycardia—Topiramate—obesity	0.000158	0.001	CcSEcCtD
Lithium—Musculoskeletal discomfort—Bupropion—obesity	0.000157	0.001	CcSEcCtD
Lithium—Body temperature increased—Sibutramine—obesity	0.000156	0.000997	CcSEcCtD
Lithium—Abdominal pain—Sibutramine—obesity	0.000156	0.000997	CcSEcCtD
Lithium—Hallucination—Topiramate—obesity	0.000154	0.000981	CcSEcCtD
Lithium—Somnolence—Bupropion—obesity	0.000153	0.000978	CcSEcCtD
Lithium—Dyspepsia—Bupropion—obesity	0.000152	0.000968	CcSEcCtD
Lithium—Decreased appetite—Bupropion—obesity	0.00015	0.000956	CcSEcCtD
Lithium—Fatigue—Bupropion—obesity	0.000149	0.000948	CcSEcCtD
Lithium—Asthenia—Orlistat—obesity	0.000147	0.000935	CcSEcCtD
Lithium—Tinnitus—Topiramate—obesity	0.000144	0.00092	CcSEcCtD
Lithium—Feeling abnormal—Bupropion—obesity	0.000142	0.000906	CcSEcCtD
Lithium—Asthenia—Sibutramine—obesity	0.000142	0.000905	CcSEcCtD
Lithium—Gastrointestinal pain—Bupropion—obesity	0.000141	0.000899	CcSEcCtD
Lithium—Diarrhoea—Orlistat—obesity	0.00014	0.000892	CcSEcCtD
Lithium—Alopecia—Topiramate—obesity	0.000137	0.000872	CcSEcCtD
Lithium—Body temperature increased—Bupropion—obesity	0.000136	0.00087	CcSEcCtD
Lithium—Abdominal pain—Bupropion—obesity	0.000136	0.00087	CcSEcCtD
Lithium—Diarrhoea—Sibutramine—obesity	0.000135	0.000863	CcSEcCtD
Lithium—Dizziness—Orlistat—obesity	0.000135	0.000862	CcSEcCtD
Lithium—Flatulence—Topiramate—obesity	0.000133	0.000846	CcSEcCtD
Lithium—Dysgeusia—Topiramate—obesity	0.000132	0.000841	CcSEcCtD
Lithium—Dizziness—Sibutramine—obesity	0.000131	0.000834	CcSEcCtD
Lithium—Vomiting—Orlistat—obesity	0.00013	0.000829	CcSEcCtD
Lithium—Rash—Orlistat—obesity	0.000129	0.000822	CcSEcCtD
Lithium—Dermatitis—Orlistat—obesity	0.000129	0.000821	CcSEcCtD
Lithium—Headache—Orlistat—obesity	0.000128	0.000817	CcSEcCtD
Lithium—Vision blurred—Topiramate—obesity	0.000127	0.000809	CcSEcCtD
Lithium—Tremor—Topiramate—obesity	0.000126	0.000804	CcSEcCtD
Lithium—Vomiting—Sibutramine—obesity	0.000126	0.000802	CcSEcCtD
Lithium—Rash—Sibutramine—obesity	0.000125	0.000796	CcSEcCtD
Lithium—Dermatitis—Sibutramine—obesity	0.000125	0.000795	CcSEcCtD
Lithium—Headache—Sibutramine—obesity	0.000124	0.00079	CcSEcCtD
Lithium—Asthenia—Bupropion—obesity	0.000124	0.000789	CcSEcCtD
Lithium—Agitation—Topiramate—obesity	0.000124	0.000789	CcSEcCtD
Lithium—Nausea—Orlistat—obesity	0.000121	0.000774	CcSEcCtD
Lithium—Vertigo—Topiramate—obesity	0.000121	0.000771	CcSEcCtD
Lithium—Syncope—Topiramate—obesity	0.000121	0.00077	CcSEcCtD
Lithium—Loss of consciousness—Topiramate—obesity	0.000118	0.000755	CcSEcCtD
Lithium—Diarrhoea—Bupropion—obesity	0.000118	0.000753	CcSEcCtD
Lithium—Nausea—Sibutramine—obesity	0.000118	0.000749	CcSEcCtD
Lithium—Convulsion—Topiramate—obesity	0.000117	0.000744	CcSEcCtD
Lithium—Arthralgia—Topiramate—obesity	0.000115	0.000731	CcSEcCtD
Lithium—Dizziness—Bupropion—obesity	0.000114	0.000727	CcSEcCtD
Lithium—Discomfort—Topiramate—obesity	0.000113	0.000722	CcSEcCtD
Lithium—Dry mouth—Topiramate—obesity	0.000112	0.000715	CcSEcCtD
Lithium—Confusional state—Topiramate—obesity	0.000111	0.000707	CcSEcCtD
Lithium—Oedema—Topiramate—obesity	0.00011	0.000701	CcSEcCtD
Lithium—Vomiting—Bupropion—obesity	0.00011	0.000699	CcSEcCtD
Lithium—Rash—Bupropion—obesity	0.000109	0.000694	CcSEcCtD
Lithium—Dermatitis—Bupropion—obesity	0.000109	0.000693	CcSEcCtD
Lithium—Shock—Topiramate—obesity	0.000108	0.000689	CcSEcCtD
Lithium—Headache—Bupropion—obesity	0.000108	0.000689	CcSEcCtD
Lithium—Anorexia—Topiramate—obesity	0.000105	0.000668	CcSEcCtD
Lithium—Hypotension—Topiramate—obesity	0.000103	0.000655	CcSEcCtD
Lithium—Nausea—Bupropion—obesity	0.000103	0.000653	CcSEcCtD
Lithium—Musculoskeletal discomfort—Topiramate—obesity	0.0001	0.000638	CcSEcCtD
Lithium—Somnolence—Topiramate—obesity	9.77e-05	0.000623	CcSEcCtD
Lithium—Dyspepsia—Topiramate—obesity	9.68e-05	0.000617	CcSEcCtD
Lithium—Decreased appetite—Topiramate—obesity	9.56e-05	0.000609	CcSEcCtD
Lithium—Fatigue—Topiramate—obesity	9.48e-05	0.000604	CcSEcCtD
Lithium—Feeling abnormal—Topiramate—obesity	9.06e-05	0.000577	CcSEcCtD
Lithium—Gastrointestinal pain—Topiramate—obesity	8.99e-05	0.000573	CcSEcCtD
Lithium—Abdominal pain—Topiramate—obesity	8.69e-05	0.000554	CcSEcCtD
Lithium—Body temperature increased—Topiramate—obesity	8.69e-05	0.000554	CcSEcCtD
Lithium—Asthenia—Topiramate—obesity	7.89e-05	0.000503	CcSEcCtD
Lithium—Diarrhoea—Topiramate—obesity	7.52e-05	0.000479	CcSEcCtD
Lithium—Dizziness—Topiramate—obesity	7.27e-05	0.000463	CcSEcCtD
Lithium—Vomiting—Topiramate—obesity	6.99e-05	0.000446	CcSEcCtD
Lithium—Rash—Topiramate—obesity	6.93e-05	0.000442	CcSEcCtD
Lithium—Dermatitis—Topiramate—obesity	6.93e-05	0.000441	CcSEcCtD
Lithium—Headache—Topiramate—obesity	6.89e-05	0.000439	CcSEcCtD
Lithium—Nausea—Topiramate—obesity	6.53e-05	0.000416	CcSEcCtD
Lithium—GSK3B—Disease—FOXO3—obesity	1.59e-05	8.93e-05	CbGpPWpGaD
Lithium—GSK3A—Immune System—ICAM1—obesity	1.59e-05	8.92e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—PRL—obesity	1.58e-05	8.9e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling by NGF—PIK3CA—obesity	1.58e-05	8.9e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—NPY—obesity	1.58e-05	8.87e-05	CbGpPWpGaD
Lithium—GSK3A—Immune System—BAD—obesity	1.57e-05	8.85e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—APOC3—obesity	1.57e-05	8.81e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—IAPP—obesity	1.57e-05	8.81e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—STK11—obesity	1.56e-05	8.77e-05	CbGpPWpGaD
Lithium—GSK3A—Disease—APOE—obesity	1.56e-05	8.76e-05	CbGpPWpGaD
Lithium—GSK3B—RNF mutants show enhanced WNT signaling and proliferation—AKT1—obesity	1.56e-05	8.75e-05	CbGpPWpGaD
Lithium—GSK3B—Innate Immune System—BCL2—obesity	1.54e-05	8.69e-05	CbGpPWpGaD
Lithium—GSK3A—Disease—CAV1—obesity	1.54e-05	8.68e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—PLG—obesity	1.54e-05	8.67e-05	CbGpPWpGaD
Lithium—GSK3B—Adaptive Immune System—PIK3R1—obesity	1.54e-05	8.66e-05	CbGpPWpGaD
Lithium—GSK3A—Disease—APOA1—obesity	1.54e-05	8.66e-05	CbGpPWpGaD
Lithium—GSK3B—Immune System—IL18—obesity	1.52e-05	8.56e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—HTR1B—obesity	1.52e-05	8.55e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—CRH—obesity	1.52e-05	8.55e-05	CbGpPWpGaD
Lithium—GSK3A—Immune System—IRS1—obesity	1.51e-05	8.47e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—FOXO3—obesity	1.51e-05	8.47e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—SDC1—obesity	1.5e-05	8.46e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—ADRB2—obesity	1.5e-05	8.44e-05	CbGpPWpGaD
Lithium—GSK3B—Cellular responses to stress—IL6—obesity	1.49e-05	8.4e-05	CbGpPWpGaD
Lithium—GSK3B—Innate Immune System—MTOR—obesity	1.48e-05	8.33e-05	CbGpPWpGaD
Lithium—GSK3B—Innate Immune System—PIK3CB—obesity	1.48e-05	8.33e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—AKR1C3—obesity	1.48e-05	8.32e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—SOCS1—obesity	1.48e-05	8.32e-05	CbGpPWpGaD
Lithium—GSK3B—Immune System—FOXO1—obesity	1.48e-05	8.31e-05	CbGpPWpGaD
Lithium—IMPA1—Metabolism—PIK3CA—obesity	1.46e-05	8.22e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—SOCS3—obesity	1.46e-05	8.21e-05	CbGpPWpGaD
Lithium—GSK3B—Developmental Biology—MMP9—obesity	1.46e-05	8.2e-05	CbGpPWpGaD
Lithium—GSK3A—Disease—BAD—obesity	1.45e-05	8.17e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling by WNT in cancer—AKT1—obesity	1.44e-05	8.12e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—NPS—obesity	1.44e-05	8.11e-05	CbGpPWpGaD
Lithium—GSK3B—Disease—APOB—obesity	1.44e-05	8.09e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—GNB3—obesity	1.43e-05	8.04e-05	CbGpPWpGaD
Lithium—GSK3B—Adaptive Immune System—PIK3CB—obesity	1.42e-05	8e-05	CbGpPWpGaD
Lithium—GSK3B—Adaptive Immune System—MTOR—obesity	1.42e-05	8e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—HTR2C—obesity	1.41e-05	7.95e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—DRD1—obesity	1.41e-05	7.95e-05	CbGpPWpGaD
Lithium—GSK3B—Immune System—CD36—obesity	1.41e-05	7.95e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—IGF2—obesity	1.4e-05	7.9e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling by NGF—IL6—obesity	1.4e-05	7.88e-05	CbGpPWpGaD
Lithium—GSK3A—Immune System—AKT2—obesity	1.39e-05	7.84e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—GNAS—obesity	1.39e-05	7.83e-05	CbGpPWpGaD
Lithium—GSK3A—Disease—IRS1—obesity	1.39e-05	7.82e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—NTRK2—obesity	1.38e-05	7.74e-05	CbGpPWpGaD
Lithium—GSK3B—Disease—LPL—obesity	1.37e-05	7.73e-05	CbGpPWpGaD
Lithium—GSK3B—Immune System—PRKCD—obesity	1.37e-05	7.71e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—ADRB1—obesity	1.37e-05	7.7e-05	CbGpPWpGaD
Lithium—GSK3B—Disease—FOXO1—obesity	1.36e-05	7.67e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—APOB—obesity	1.36e-05	7.67e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—PARP1—obesity	1.34e-05	7.54e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—GHRL—obesity	1.34e-05	7.54e-05	CbGpPWpGaD
Lithium—GSK3B—Immune System—C3—obesity	1.34e-05	7.53e-05	CbGpPWpGaD
Lithium—IMPA2—Metabolism—AKT1—obesity	1.34e-05	7.53e-05	CbGpPWpGaD
Lithium—GSK3A—Immune System—PIK3CD—obesity	1.34e-05	7.53e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—CCL5—obesity	1.33e-05	7.49e-05	CbGpPWpGaD
Lithium—GSK3A—Disease—INS—obesity	1.33e-05	7.49e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—DRD4—obesity	1.33e-05	7.48e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—LPL—obesity	1.3e-05	7.32e-05	CbGpPWpGaD
Lithium—GSK3B—Developmental Biology—STAT3—obesity	1.3e-05	7.29e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling by NGF—AKT1—obesity	1.29e-05	7.27e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—FOXO1—obesity	1.29e-05	7.27e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—RPS6KB1—obesity	1.29e-05	7.26e-05	CbGpPWpGaD
Lithium—GSK3A—Immune System—TYK2—obesity	1.29e-05	7.24e-05	CbGpPWpGaD
Lithium—GSK3A—Disease—AKT2—obesity	1.29e-05	7.24e-05	CbGpPWpGaD
Lithium—GSK3B—Immune System—IRS2—obesity	1.27e-05	7.17e-05	CbGpPWpGaD
Lithium—GSK3B—Immune System—CRP—obesity	1.27e-05	7.17e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—CNR1—obesity	1.27e-05	7.14e-05	CbGpPWpGaD
Lithium—GSK3B—Axon guidance—IL6—obesity	1.27e-05	7.13e-05	CbGpPWpGaD
Lithium—GSK3B—Disease—PRKCD—obesity	1.27e-05	7.12e-05	CbGpPWpGaD
Lithium—GSK3A—Immune System—PIK3R1—obesity	1.26e-05	7.11e-05	CbGpPWpGaD
Lithium—GSK3B—Innate Immune System—MAPK8—obesity	1.25e-05	7.04e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—TCF7L2—obesity	1.25e-05	7.01e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—DRD2—obesity	1.24e-05	6.96e-05	CbGpPWpGaD
Lithium—GSK3B—Disease—MTHFR—obesity	1.24e-05	6.96e-05	CbGpPWpGaD
Lithium—GSK3A—Disease—PIK3CD—obesity	1.24e-05	6.95e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—PTPN1—obesity	1.23e-05	6.89e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—GCG—obesity	1.23e-05	6.89e-05	CbGpPWpGaD
Lithium—GSK3A—Disease—SERPINE1—obesity	1.22e-05	6.88e-05	CbGpPWpGaD
Lithium—GSK3B—Immune System—TLR4—obesity	1.22e-05	6.87e-05	CbGpPWpGaD
Lithium—GSK3A—Innate Immune System—PIK3CA—obesity	1.22e-05	6.87e-05	CbGpPWpGaD
Lithium—GSK3A—Immune System—BCL2—obesity	1.22e-05	6.85e-05	CbGpPWpGaD
Lithium—GSK3A—Immune System—IFNG—obesity	1.21e-05	6.78e-05	CbGpPWpGaD
Lithium—GSK3B—Developmental Biology—TGFB1—obesity	1.2e-05	6.76e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—PRKCD—obesity	1.2e-05	6.75e-05	CbGpPWpGaD
Lithium—IMPA1—Metabolism—AKT1—obesity	1.19e-05	6.71e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling by Wnt—AKT1—obesity	1.19e-05	6.7e-05	CbGpPWpGaD
Lithium—GSK3A—Disease—TYK2—obesity	1.19e-05	6.69e-05	CbGpPWpGaD
Lithium—GSK3A—Disease—RHOA—obesity	1.18e-05	6.63e-05	CbGpPWpGaD
Lithium—GSK3B—Disease—IRS2—obesity	1.18e-05	6.62e-05	CbGpPWpGaD
Lithium—GSK3B—Immune System—PRKCB—obesity	1.18e-05	6.61e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—HTR2A—obesity	1.17e-05	6.6e-05	CbGpPWpGaD
Lithium—GSK3A—Adaptive Immune System—PIK3CA—obesity	1.17e-05	6.6e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—C3—obesity	1.17e-05	6.59e-05	CbGpPWpGaD
Lithium—GSK3B—Immune System—ICAM1—obesity	1.17e-05	6.59e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—PRL—obesity	1.17e-05	6.58e-05	CbGpPWpGaD
Lithium—GSK3A—Disease—PIK3R1—obesity	1.17e-05	6.57e-05	CbGpPWpGaD
Lithium—GSK3A—Disease—NOS3—obesity	1.17e-05	6.57e-05	CbGpPWpGaD
Lithium—GSK3A—Immune System—PIK3CB—obesity	1.17e-05	6.56e-05	CbGpPWpGaD
Lithium—GSK3A—Immune System—MTOR—obesity	1.17e-05	6.56e-05	CbGpPWpGaD
Lithium—GSK3B—Immune System—BAD—obesity	1.16e-05	6.54e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—STK11—obesity	1.15e-05	6.48e-05	CbGpPWpGaD
Lithium—GSK3B—Disease—APOE—obesity	1.15e-05	6.48e-05	CbGpPWpGaD
Lithium—GSK3B—Disease—CAV1—obesity	1.14e-05	6.42e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—PLG—obesity	1.14e-05	6.41e-05	CbGpPWpGaD
Lithium—GSK3B—Disease—APOA1—obesity	1.14e-05	6.4e-05	CbGpPWpGaD
Lithium—GSK3B—Developmental Biology—TNF—obesity	1.12e-05	6.31e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—IRS2—obesity	1.11e-05	6.27e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—AGT—obesity	1.11e-05	6.26e-05	CbGpPWpGaD
Lithium—GSK3B—Immune System—IRS1—obesity	1.11e-05	6.26e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—FOXO3—obesity	1.11e-05	6.26e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—ADRB2—obesity	1.11e-05	6.24e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—SOCS1—obesity	1.09e-05	6.15e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—APOE—obesity	1.09e-05	6.14e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—LEP—obesity	1.09e-05	6.14e-05	CbGpPWpGaD
Lithium—GSK3A—Innate Immune System—IL6—obesity	1.08e-05	6.08e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—CAV1—obesity	1.08e-05	6.08e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—SOCS3—obesity	1.08e-05	6.07e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—APOA1—obesity	1.08e-05	6.07e-05	CbGpPWpGaD
Lithium—GSK3A—Disease—PIK3CB—obesity	1.08e-05	6.06e-05	CbGpPWpGaD
Lithium—GSK3A—Disease—MTOR—obesity	1.08e-05	6.06e-05	CbGpPWpGaD
Lithium—GSK3A—Immune System—IL1B—obesity	1.08e-05	6.05e-05	CbGpPWpGaD
Lithium—GSK3B—Disease—BAD—obesity	1.07e-05	6.03e-05	CbGpPWpGaD
Lithium—GSK3A—Disease—PTGS2—obesity	1.07e-05	6.01e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—GNB3—obesity	1.06e-05	5.94e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—ESR1—obesity	1.04e-05	5.86e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—IGF2—obesity	1.04e-05	5.84e-05	CbGpPWpGaD
Lithium—GSK3B—Immune System—AKT2—obesity	1.03e-05	5.79e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—F2—obesity	1.03e-05	5.79e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—PRKCB—obesity	1.03e-05	5.79e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—GNAS—obesity	1.03e-05	5.79e-05	CbGpPWpGaD
Lithium—GSK3B—Disease—IRS1—obesity	1.03e-05	5.78e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—BAD—obesity	1.02e-05	5.72e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—APOB—obesity	1.01e-05	5.67e-05	CbGpPWpGaD
Lithium—GSK3A—Innate Immune System—AKT1—obesity	9.98e-06	5.61e-05	CbGpPWpGaD
Lithium—GSK3B—Immune System—PIK3CD—obesity	9.89e-06	5.56e-05	CbGpPWpGaD
Lithium—GSK3A—Immune System—MAPK8—obesity	9.86e-06	5.55e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—PIK3CG—obesity	9.85e-06	5.54e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—CCL5—obesity	9.84e-06	5.53e-05	CbGpPWpGaD
Lithium—GSK3B—Disease—INS—obesity	9.84e-06	5.53e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—IRS1—obesity	9.73e-06	5.47e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—LPL—obesity	9.62e-06	5.41e-05	CbGpPWpGaD
Lithium—GSK3A—Adaptive Immune System—AKT1—obesity	9.58e-06	5.39e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—FOXO1—obesity	9.55e-06	5.37e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—RPS6KB1—obesity	9.53e-06	5.36e-05	CbGpPWpGaD
Lithium—GSK3B—Immune System—TYK2—obesity	9.52e-06	5.35e-05	CbGpPWpGaD
Lithium—GSK3B—Disease—AKT2—obesity	9.51e-06	5.35e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—POMC—obesity	9.37e-06	5.27e-05	CbGpPWpGaD
Lithium—GSK3B—Immune System—PIK3R1—obesity	9.34e-06	5.25e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—INS—obesity	9.32e-06	5.24e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—CCL2—obesity	9.17e-06	5.16e-05	CbGpPWpGaD
Lithium—GSK3B—Disease—PIK3CD—obesity	9.13e-06	5.14e-05	CbGpPWpGaD
Lithium—GSK3B—Developmental Biology—IL6—obesity	9.05e-06	5.09e-05	CbGpPWpGaD
Lithium—GSK3B—Disease—SERPINE1—obesity	9.03e-06	5.08e-05	CbGpPWpGaD
Lithium—GSK3B—Innate Immune System—PIK3CA—obesity	9.03e-06	5.08e-05	CbGpPWpGaD
Lithium—GSK3A—Immune System—STAT3—obesity	9.02e-06	5.07e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—IGF1—obesity	9.02e-06	5.07e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—AKT2—obesity	9.01e-06	5.07e-05	CbGpPWpGaD
Lithium—GSK3B—Immune System—BCL2—obesity	8.99e-06	5.06e-05	CbGpPWpGaD
Lithium—GSK3B—Immune System—IFNG—obesity	8.91e-06	5.01e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—PRKCD—obesity	8.86e-06	4.98e-05	CbGpPWpGaD
Lithium—GSK3B—Disease—TYK2—obesity	8.79e-06	4.94e-05	CbGpPWpGaD
Lithium—GSK3B—Disease—RHOA—obesity	8.72e-06	4.9e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—HTR2A—obesity	8.67e-06	4.88e-05	CbGpPWpGaD
Lithium—GSK3B—Adaptive Immune System—PIK3CA—obesity	8.67e-06	4.88e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—C3—obesity	8.66e-06	4.87e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—PIK3CD—obesity	8.66e-06	4.87e-05	CbGpPWpGaD
Lithium—GSK3B—Disease—NOS3—obesity	8.63e-06	4.85e-05	CbGpPWpGaD
Lithium—GSK3B—Disease—PIK3R1—obesity	8.63e-06	4.85e-05	CbGpPWpGaD
Lithium—GSK3B—Immune System—MTOR—obesity	8.62e-06	4.85e-05	CbGpPWpGaD
Lithium—GSK3B—Immune System—PIK3CB—obesity	8.62e-06	4.85e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—SERPINE1—obesity	8.56e-06	4.82e-05	CbGpPWpGaD
Lithium—GSK3B—Developmental Biology—AKT1—obesity	8.35e-06	4.7e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—TYK2—obesity	8.33e-06	4.68e-05	CbGpPWpGaD
Lithium—GSK3A—Disease—STAT3—obesity	8.33e-06	4.68e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—RHOA—obesity	8.26e-06	4.65e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—IRS2—obesity	8.24e-06	4.63e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—AGT—obesity	8.23e-06	4.63e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—NOS3—obesity	8.17e-06	4.6e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—PIK3R1—obesity	8.17e-06	4.6e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—LEP—obesity	8.06e-06	4.54e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—APOE—obesity	8.06e-06	4.54e-05	CbGpPWpGaD
Lithium—GSK3B—Innate Immune System—IL6—obesity	7.99e-06	4.5e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—CAV1—obesity	7.99e-06	4.49e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—APOA1—obesity	7.97e-06	4.48e-05	CbGpPWpGaD
Lithium—GSK3B—Disease—MTOR—obesity	7.96e-06	4.48e-05	CbGpPWpGaD
Lithium—GSK3B—Disease—PIK3CB—obesity	7.96e-06	4.48e-05	CbGpPWpGaD
Lithium—GSK3B—Immune System—IL1B—obesity	7.95e-06	4.47e-05	CbGpPWpGaD
Lithium—GSK3B—Disease—PTGS2—obesity	7.89e-06	4.44e-05	CbGpPWpGaD
Lithium—GSK3A—Disease—MYC—obesity	7.74e-06	4.35e-05	CbGpPWpGaD
Lithium—GSK3A—Disease—TGFB1—obesity	7.72e-06	4.34e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—ESR1—obesity	7.7e-06	4.33e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—F2—obesity	7.6e-06	4.28e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—PRKCB—obesity	7.6e-06	4.28e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—MTOR—obesity	7.55e-06	4.24e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—PIK3CB—obesity	7.55e-06	4.24e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—BAD—obesity	7.51e-06	4.23e-05	CbGpPWpGaD
Lithium—GSK3B—Innate Immune System—AKT1—obesity	7.37e-06	4.15e-05	CbGpPWpGaD
Lithium—GSK3B—Immune System—MAPK8—obesity	7.29e-06	4.1e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—PIK3CG—obesity	7.28e-06	4.09e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—IRS1—obesity	7.19e-06	4.05e-05	CbGpPWpGaD
Lithium—GSK3A—Immune System—PIK3CA—obesity	7.11e-06	4e-05	CbGpPWpGaD
Lithium—GSK3B—Adaptive Immune System—AKT1—obesity	7.08e-06	3.98e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—POMC—obesity	6.93e-06	3.9e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—INS—obesity	6.89e-06	3.87e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—CCL2—obesity	6.78e-06	3.81e-05	CbGpPWpGaD
Lithium—GSK3B—Immune System—STAT3—obesity	6.66e-06	3.75e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—IGF1—obesity	6.66e-06	3.75e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—AKT2—obesity	6.66e-06	3.74e-05	CbGpPWpGaD
Lithium—GSK3A—Disease—PIK3CA—obesity	6.57e-06	3.69e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—MMP9—obesity	6.56e-06	3.69e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—PIK3CD—obesity	6.4e-06	3.6e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—MAPK8—obesity	6.38e-06	3.59e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—SERPINE1—obesity	6.33e-06	3.56e-05	CbGpPWpGaD
Lithium—GSK3A—Immune System—IL6—obesity	6.3e-06	3.54e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—TYK2—obesity	6.15e-06	3.46e-05	CbGpPWpGaD
Lithium—GSK3B—Disease—STAT3—obesity	6.15e-06	3.46e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—RHOA—obesity	6.1e-06	3.43e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—PIK3R1—obesity	6.04e-06	3.4e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—NOS3—obesity	6.04e-06	3.4e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—STAT3—obesity	5.83e-06	3.28e-05	CbGpPWpGaD
Lithium—GSK3A—Disease—IL6—obesity	5.82e-06	3.27e-05	CbGpPWpGaD
Lithium—GSK3A—Immune System—AKT1—obesity	5.81e-06	3.27e-05	CbGpPWpGaD
Lithium—GSK3B—Disease—MYC—obesity	5.72e-06	3.22e-05	CbGpPWpGaD
Lithium—GSK3B—Disease—TGFB1—obesity	5.7e-06	3.21e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—MTOR—obesity	5.58e-06	3.14e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—PIK3CB—obesity	5.58e-06	3.14e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—MYC—obesity	5.42e-06	3.05e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—TGFB1—obesity	5.4e-06	3.04e-05	CbGpPWpGaD
Lithium—GSK3A—Disease—AKT1—obesity	5.37e-06	3.02e-05	CbGpPWpGaD
Lithium—GSK3B—Immune System—PIK3CA—obesity	5.26e-06	2.96e-05	CbGpPWpGaD
Lithium—GSK3B—Disease—PIK3CA—obesity	4.85e-06	2.73e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—MMP9—obesity	4.85e-06	2.73e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—MAPK8—obesity	4.71e-06	2.65e-05	CbGpPWpGaD
Lithium—GSK3B—Immune System—IL6—obesity	4.65e-06	2.62e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—PIK3CA—obesity	4.6e-06	2.59e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—STAT3—obesity	4.31e-06	2.42e-05	CbGpPWpGaD
Lithium—GSK3B—Disease—IL6—obesity	4.3e-06	2.42e-05	CbGpPWpGaD
Lithium—GSK3B—Immune System—AKT1—obesity	4.29e-06	2.42e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—IL6—obesity	4.07e-06	2.29e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—MYC—obesity	4e-06	2.25e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—TGFB1—obesity	3.99e-06	2.25e-05	CbGpPWpGaD
Lithium—GSK3B—Disease—AKT1—obesity	3.96e-06	2.23e-05	CbGpPWpGaD
Lithium—GSK3A—Signaling Pathways—AKT1—obesity	3.76e-06	2.11e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—PIK3CA—obesity	3.4e-06	1.91e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—IL6—obesity	3.01e-06	1.69e-05	CbGpPWpGaD
Lithium—GSK3B—Signaling Pathways—AKT1—obesity	2.78e-06	1.56e-05	CbGpPWpGaD
